(Q45777654)

15 December 2017

title

Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS. (English)

1 reference

15 December 2017

author

Antonio Simone Laganà

series ordinal

2

1 reference

15 December 2017

author name string

Alfonsa Pizzo

series ordinal

1

1 reference

15 December 2017

Luisa Barbaro

series ordinal

3

1 reference

15 December 2017

publication date

19 December 2013

1 reference

15 December 2017

Gynecological Endocrinology

published in

1 reference

15 December 2017

volume

30

1 reference

15 December 2017

issue

3

1 reference

15 December 2017

page(s)

205-208

1 reference

15 December 2017

The prevalence and features of the polycystic ovary syndrome in an unselected population

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.860120

Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.860120

Polycystic ovary syndrome: a changing perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.860120

Androgens and insulin--two key players in polycystic ovary syndrome. Recent concepts in the pathophysiology and genetics of polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.860120

Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.860120

Androgen excess is the key element in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.860120

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.860120

Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.860120

Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.860120

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.860120

Contribution of myo-inositol to reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.860120

Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.860120

Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.860120

10.3109/09513590.2013.860120

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017